Neurocrine Biosciences Inc
NASDAQ:NBIX

Watchlist Manager
Neurocrine Biosciences Inc Logo
Neurocrine Biosciences Inc
NASDAQ:NBIX
Watchlist
Price: 124.61 USD 0.07% Market Closed
Market Cap: 12.3B USD

Intrinsic Value

The intrinsic value of one NBIX stock under the Base Case scenario is 129.09 USD. Compared to the current market price of 124.61 USD, Neurocrine Biosciences Inc is Undervalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NBIX Intrinsic Value
129.09 USD
Undervaluation 3%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Neurocrine Biosciences Inc

Valuation History Unavailable

Historical valuation for NBIX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Neurocrine Biosciences’ heavy reliance on Ingrezza for the bulk of its revenue leaves the company vulnerable should sales or market share of this core product decline, exposing a significant revenue concentration risk.

Bull Theses

Ingrezza continues to show strong sales momentum, fueled by expanding market penetration for tardive dyskinesia and steady physician adoption, supporting robust cash flows.

Show More Less
How do you feel about NBIX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Neurocrine Biosciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neurocrine Biosciences Inc

Current Assets 1.6B
Cash & Short-Term Investments 943.5m
Receivables 516m
Other Current Assets 178.4m
Non-Current Assets 2B
Long-Term Investments 909.5m
PP&E 589.2m
Intangibles 36.4m
Other Non-Current Assets 514.7m
Efficiency

Free Cash Flow Analysis
Neurocrine Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Neurocrine Biosciences Inc

Revenue
2.4B USD
Cost of Revenue
-35.7m USD
Gross Profit
2.4B USD
Operating Expenses
-1.9B USD
Operating Income
501.4m USD
Other Expenses
-195.6m USD
Net Income
305.8m USD
Fundamental Scores

NBIX Profitability Score
Profitability Due Diligence

Neurocrine Biosciences Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Years Revenue Growth
Positive 3-Year Average ROIC
65/100
Profitability
Score

Neurocrine Biosciences Inc's profitability score is 65/100. The higher the profitability score, the more profitable the company is.

NBIX Solvency Score
Solvency Due Diligence

Neurocrine Biosciences Inc's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
89/100
Solvency
Score

Neurocrine Biosciences Inc's solvency score is 89/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NBIX Price Targets Summary
Neurocrine Biosciences Inc

Wall Street analysts forecast NBIX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NBIX is 160.68 USD with a low forecast of 116.15 USD and a high forecast of 201.6 USD.

Lowest
Price Target
116.15 USD
7% Downside
Average
Price Target
160.68 USD
29% Upside
Highest
Price Target
201.6 USD
62% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Neurocrine Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NBIX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

NBIX Insider Trading
Buy and sell transactions by insiders

NBIX News

Other Videos
What is the Intrinsic Value of one NBIX stock?

The intrinsic value of one NBIX stock under the Base Case scenario is 129.09 USD.

Is NBIX stock undervalued or overvalued?

Compared to the current market price of 124.61 USD, Neurocrine Biosciences Inc is Undervalued by 3%.

Back to Top